Kymera Therapeutics (KYMR) Share-based Compensation (2019 - 2026)
Kymera Therapeutics (KYMR) recorded Share-based Compensation of $18.94 million in Q2 2026, up 22.9% from $15.42 million a year earlier and up 18.3% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Share-based Compensation (2019 - 2026) Analysis & Trends
On a TTM basis, Kymera Therapeutics' Share-based Compensation came in at $65.2 million as of Jun 30, 2026, up 11.7% year-over-year; for FY2025, it came in at $59.9 million, up 8.9% from FY2024.
- Annual Share-based Compensation has increased for six straight years, with a five-year compound annual growth rate of 63.1% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $55.01 million in FY2024 (+27.6%), $43.12 million in FY2023 (+21.5%), $35.48 million in FY2022 (+42.1%) and $24.97 million in FY2021 (+381.2%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q3 2019.
- On a year-over-year basis, Share-based Compensation has increased for 24 consecutive quarters, with growth averaging 15.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation ran from 2.7% in Q4 2022 to 375.0% in Q4 2021.
- Per Business Quant, the preceding three quarters came in at $16.01 million (Q1 2026), $14.45 million (Q4 2025) and $15.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 18.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.84 Mn |
| Jun 30, 2026 | 18.94 Mn |
| Mar 31, 2026 | 16.01 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Sep 30, 2025 | 15.80 Mn |
| Jun 30, 2025 | 15.42 Mn |
| Mar 31, 2025 | 14.23 Mn |
| Dec 31, 2024 | 13.80 Mn |
| Sep 30, 2024 | 14.90 Mn |
| Jun 30, 2024 | 14.34 Mn |
| Mar 31, 2024 | 11.97 Mn |
| Dec 31, 2023 | 10.90 Mn |
| Sep 30, 2023 | 11.66 Mn |
| Jun 30, 2023 | 11.18 Mn |
| Mar 31, 2023 | 9.39 Mn |
| Dec 31, 2022 | 8.91 Mn |
| Sep 30, 2022 | 9.08 Mn |
| Jun 30, 2022 | 9.62 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 8.68 Mn |
API Access
Kymera Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();